Literature DB >> 32936425

Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Marianna Fabi1, Laura Andreozzi2, Ilaria Frabboni2, Ada Dormi3, Elena Corinaldesi4, Francesca Lami5, Cristina Cicero6, Bertrand Tchana7, Rosa Francavilla8, Monica Sprocati9, Barbara Bigucci10, Claudia Balsamo11, Paola Sogno Valin12, Giorgia Di Fazzio13, Lorenzo Iughetti5, Enrico Valletta14, Federico Marchetti15, Andrea Donti16, Marcello Lanari2.   

Abstract

OBJECTIVES: Kawasaki disease (KD) is the most frequent cause of acquired heart disease in children in high-income countries because of coronary artery involvement. Risk factors for coronary lesions can vary in consideration of different genetic background and environmental factors.
METHODS: Multicenter retrospective and prospective study including 372 consecutive children (58% boys; mean age 34.3 ± 30.3 months, Caucasian 85%) was diagnosed with KD. We divided the cohort into 2 groups according to the presence of coronary anomalies (CAA) and aneurysms. We compared the groups and studied the risk factors for CAA and for aneurysms, the most severe lesions.
RESULTS: Children with CAA were 91/372 (24.46%, aneurysms 20/372, 5.37%). Children with CAA were more likely to have a longer duration of fever (p < 0.001), later day of treatment (p < 0.001), to be IVIG non-responders and late treated (p < 0.001), while age, clinical presentation, and seasonality were not different. They also had significantly higher WBC and neutrophils, lower lymphocytes, Hb and Na during the acute stage, and slower resolution of inflammation. Age, IVIG unresponsiveness, and presence of non-coronary cardiac findings were independent risk factors for CAA and for aneurysms, while neutrophils just for CAA. Age under 6 months was a risk factor for the aneurysm. Aneurysms occurred more frequently in the first quartile of the age of KD onset (under 14 months).
CONCLUSION: Very young children with non-coronary cardiac findings are at increased risk for a more severe form of KD with aneurysms. These children could benefit from adjunctive therapy beside IVIG, especially if they have higher markers of inflammation, particularly neutrophils. Key points • Risk factors for coronary lesions can vary in consideration of different genetic background and environmental factors. • Risk factors for coronary involvement have been extensively studied in the Asian population, and others have been validated in cohorts with mixed ethnicities. • In our predominantly Caucasian population, non-coronary cardiac findings, age younger than 6 months, and IVIG unresponsiveness are independent risk factors for a more severe form of KD with aneurysms.

Entities:  

Keywords:  Caucasian; Coronary aneurysms; Coronary lesions; Kawasaki disease; Non-coronary lesions; Seasonality

Mesh:

Substances:

Year:  2020        PMID: 32936425     DOI: 10.1007/s10067-020-05331-w

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  Initial intravenous gammaglobulin treatment failure in Kawasaki disease.

Authors:  C A Wallace; J W French; S J Kahn; D D Sherry
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

2.  Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Authors:  Tohru Kobayashi; Tsutomu Saji; Tetsuya Otani; Kazuo Takeuchi; Tetsuya Nakamura; Hirokazu Arakawa; Taichi Kato; Toshiro Hara; Kenji Hamaoka; Shunichi Ogawa; Masaru Miura; Yuichi Nomura; Shigeto Fuse; Fukiko Ichida; Mitsuru Seki; Ryuji Fukazawa; Chitose Ogawa; Kenji Furuno; Hirohide Tokunaga; Shinichi Takatsuki; Shinya Hara; Akihiro Morikawa
Journal:  Lancet       Date:  2012-03-08       Impact factor: 79.321

3.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

4.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.

Authors:  Tetsuya Sano; Shunji Kurotobi; Kouji Matsuzaki; Takehisa Yamamoto; Ichiro Maki; Kazunori Miki; Shigetoyo Kogaki; Junichi Hara
Journal:  Eur J Pediatr       Date:  2006-08-01       Impact factor: 3.183

5.  Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.

Authors:  Hiromichi Hamada; Hiroyuki Suzuki; Yoshihiro Onouchi; Ryota Ebata; Masaru Terai; Shigeto Fuse; Yoshitomo Okajima; Shunji Kurotobi; Katsuki Hirai; Takashi Soga; Yukiko Ishiguchi; Yoshiaki Okuma; Nobuyuki Takada; Masaaki Yanai; Junichi Sato; Mami Nakayashiro; Mamoru Ayusawa; Eiichi Yamamoto; Yuichi Nomura; Yuya Hashimura; Kazunobu Ouchi; Hiroshi Masuda; Shinichi Takatsuki; Keiichi Hirono; Tadashi Ariga; Takashi Higaki; Akio Otsuki; Moe Terauchi; Reiko Aoyagi; Takatoshi Sato; Yasuhisa Fujii; Tadami Fujiwara; Hideki Hanaoka; Akira Hata
Journal:  Lancet       Date:  2019-03-07       Impact factor: 79.321

6.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Kimiyasu Egami; Hiromi Muta; Masahiro Ishii; Kenji Suda; Yoko Sugahara; Motofumi Iemura; Toyojiro Matsuishi
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.

Authors:  Nobuko Makino; Yosikazu Nakamura; Mayumi Yashiro; Koki Kosami; Yuri Matsubara; Ryusuke Ae; Yasuko Aoyama; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2019-04-16       Impact factor: 1.524

Review 9.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

10.  Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease.

Authors:  Keishin Sunagawa; Masako Mitsumata; Mamoru Ayusawa; Yoshiaki Kusumi
Journal:  Pediatr Cardiol       Date:  2008-06-06       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.